| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. (KYMR) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 40 sells. KYMR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.96M | $719.45M | - | |
| Dir | 2.22M | $200.74M | - | |
| Dir | 685.4K | $61.98M | - | |
| CEO | 666.2K | $60.24M | - | |
| CFO | 306.6K | $27.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | Mainolfi Nello70 | Chief Executive Officer | Sale+OE | 48,000 | $53.31 | $2,558,742.25 | -0.9% | -28.1% | -33.8% | |
| Dec 3, 2021 | Jacobs Bruce N.74 | Chief Financial Officer | Sale+OE | 10,000 | $53.56 | $535,637.02 | -15.4% | -29.0% | -42.1% | |
| Nov 2, 2021 | Gollob Jared70 | Chief Medical Officer | Sale+OE | 57,493 | $62.16 | $3,573,657.91 | -19.4% | -35.5% | -55.9% | |
| Oct 11, 2021 | Mainolfi Nello70 | Chief Executive Officer | Sale+OE | 48,000 | $56.34 | $2,704,536.28 | -1.3% | +3.4% | -62.2% | |
| Sep 3, 2021 | Jacobs Bruce N.74 | Chief Financial Officer | Sale+OE | 10,000 | $60.12 | $601,180.05 | -38.4% | -9.8% | -54.3% | |
| Aug 27, 2021 | Chesworth Richard | Chief Scientific Officer | Sale+OE | 33,779 | $60.12 | $2,030,864.42 | -100% | -10.7% | -48.5% | |
| Aug 17, 2021 | Chesworth Richard | Chief Scientific Officer | Sale+OE | 54,000 | $50.37 | $2,720,181.82 | -52.6% | +17.5% | -44.9% | |
| Aug 11, 2021 | Atlas Venture Associates X, L.P.88 | 10% Owner | Sell | 242,133 | $61.00 | $14,770,113.00 | -100% | +15.6% | -42.7% | |
| Aug 11, 2021 | Booth Bruce70 | Director | Sell | 242,133 | $61.00 | $14,770,113.00 | -100% | +15.6% | -42.7% | |
| Aug 4, 2021 | Mainolfi Nello70 | Chief Executive Officer | Sale+OE | 6,706 | $60.06 | $402,786.30 | -0.7% | +7.0% | -53.8% |